(SYNH) – FDA
-
Creative Medical Technology (CELZ) Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201
-
Syneos Health (SYNH) and Haystack Health Partner to Accelerate Clinical Trials with AI
-
-
-
Back to SYNH Stock Lookup